Altimmune said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass. Altimmune is one of several smaller biotech companies pushing to ...

The diabetes drug Mounjaro will be tested alongside an experimental treatment to study how to maintain muscle mass while losing weight, according to an announcement Thursday—after earlier studies ...

Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill that lowers blood sugar and boosts fat burning without cutting appetite or ...

Metformin's anti-senescent properties have been demonstrated through pre-clinical studies. To test the intervention in humans, the team recruited 20 healthy male and female older adults for a ...

New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while ...

(Reuters) -Fulcrum Therapeutics said on Thursday its experimental drug to treat a type of muscle disorder failed to meet the main goal in a late-stage study, sending the company's shares down nearly ...